comparison of efficacy of topical phenytoin versus topical flucinolon in treatment of cutaneous lichen planus
Phase 2
Recruiting
- Conditions
- cutaneous lichen planus.Other lichen planus
- Registration Number
- IRCT2017081231028N3
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
inclusion criteria: patients with cutaneous lichen planus visiting at Faghihi Hospital in 2013 - 2018
exclusion criteria: pregnant and lactating woman; use of systemic or topical steroid in last 1 month; sensitivity reaction to phenytoin or fluocinolone; patient has oral, genital, actinic, pigmentosus type of lichen planus; concomitant lichenplanopilaris.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Color of lesions. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Scale. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Thickness of lesion. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: Physical exam.;Pruritus. Timepoint: before starting of treatment and 2,4 and 8 weeks after start of treatment. Method of measurement: announcing the patient.
- Secondary Outcome Measures
Name Time Method